Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02YIJ
|
||||
Former ID |
DIB020083
|
||||
Drug Name |
isocarbacyclin
|
||||
Synonyms |
9-O-methanoprostaglandin I
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539234] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H34O4
|
||||
InChI |
InChI=1S/C21H34O4/c1-2-3-4-8-17(22)10-11-18-19-13-15(7-5-6-9-21(24)25)12-16(19)14-20(18)23/h10-12,16-20,22-23H,2-9,13-14H2,1H3,(H,24,25)/b11-10+/t16-,17-,18+,19-,20+/m0/s1
|
||||
InChIKey |
JANVYOZZTKSZGN-WCAFQOMDSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostacyclin receptor | Target Info | Agonist | [534478] | |
Prostaglandin E2 receptor EP3 subtype | Target Info | Agonist | [534478] | ||
Prostaglandin E2receptor, EP2 subtype | Target Info | Agonist | [534478] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Vascular smooth muscle contraction | |||||
Platelet activationhsa04020:Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Pathways in cancerhsa04024:cAMP signaling pathway | |||||
Inflammatory mediator regulation of TRP channels | |||||
Renin secretion | |||||
Pathways in cancer | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Thromboxane A2 receptor signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.